Searched for
NOVO NORDISK 2025 FORECAST
Colgate-Palmolive India bets on rural expansion, science-led innovation to drive growth towards 2030Colgate-Palmolive India is prioritizing rural market expansion, innovation, and digital transformation to boost growth. The company aims to...- Nokia: How a forgotten stock from Finland doubled investors wealth in AI comeback storyNokia shares have doubled in 2026 as investors increasingly view the company as an AI infrastructure player. Strong cloud and AI orders, br...
- Citi sees brent crude sliding to $60/bbl as supply fears easeGeopolitical tensions easing around the Strait of Hormuz are expected to drive Brent crude prices down to $60 a barrel by year-end, accordi...
- Microsoft launches firm to help companies adopt AI with $2.5 billionMicrosoft has launched a new venture, Microsoft Frontier Company, backed by $2.5 billion, to guide businesses in selecting and integrating ...
- Medical device maker Zimmer Biomet to hire 500 employees in 3 years for tech centre in IndiaMedical device giant Zimmer Biomet is set to significantly expand its Indian footprint by hiring 500 professionals over three years for its...
- Shantha Biologics to Make Injectable Drug Cartridges for Novo NordiskShantha Biologics has secured a significant contract with Danish pharmaceutical giant Novo Nordisk to manufacture cartridges for injectable...
- Southwest monsoon reaches Delhi five days behind scheduleDelhi finally welcomed the Southwest Monsoon on Thursday, five days past its usual arrival. This marks the first July monsoon since 2021, w...
- Growth engine revving as GST, auto sales rise despite global roadblocksIndia's economy shows robust growth in Q1 FY27, with GST collections soaring 13.9% to Rs 1.95 lakh crore in June. Car sales surged 24%, and...
- India's June power consumption rises 11.6% on heatwave, delayed monsoonIndia's power consumption surged by 11.62% in June, reaching 166.46 billion units, driven by a severe heatwave and delayed monsoon. This pu...
- US job openings stayed at a surprisingly strong 7.6 million in MayDespite the economic fallout from the Iran war and soaring energy prices, the U.S. job market shows surprising strength. Job openings in Ma...
- Waaree Energies shares crash 5%. Can this US ruling dent solar panel maker's image for long?Waaree Energies shares fell nearly 5% after a US Customs ruling triggered concerns over reputational impact despite the company’s clarifica...
- More than 1,300 excess deaths recorded in Europe heatwave: WHOThe World Health Organization said Sunday that over 1,300 excess deaths had been recorded in Europe since June 21 in connection with the re...
- Europe heatwave: 191 million people to face 35C+ temperatures on SundayEurope is bracing for a scorching Sunday as an estimated 191 million people are expected to face temperatures of 35C or higher, particularl...
- India’s GLP-1 boom loses steam as price war, weak retention hit generic weight-loss drug salesInitial excitement for India's generic weight-loss drugs is fading. Domestic manufacturers are lowering sales targets due to slower-than-ex...
- Healthium Medtech CEO Anish Bafna steps down, moves to non-executive chairman roleHealthium Medtech's CEO Anish Bafna is transitioning to non-executive chairman as KKR-owned company seeks a new chief within a month. Bafna...
- Bombay HC cancels 'Duphachrit' trademark, rules it deceptively similar to Abbott's 'Dupha' familyThe Bombay High Court has cancelled Thane-based Menschlich Healthcare's trademark 'Duphachrit' in favour of Abbott Product Operations AG. T...
- Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...
- UK approves Novo weight-loss pill to edge open European marketBritain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatme...
- Novo Nordisk hit by cyber incident, probes data breachDanish drugmaker Novo Nordisk has confirmed a security incident. Unauthorised access to internal IT systems occurred. Certain non-public da...
- India’s anti-obesity drug market sees slower growth after initial surge in generic semaglutide salesIndia's anti-obesity drug market sees a slowdown after initial generic semaglutide sales. Demand has eased from its peak, with growth moder...
Load More
